Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associate.

作者: James R. Wright , Dauna Crooks , Peter M. Ellis , Deborah Mings , Tim J. Whelan

DOI: 10.1002/CNCR.10864

关键词:

摘要: BACKGROUND The multiple determinants of a patient's decision to enter into clinical trial have been explored largely from the perspectives patients and their physicians. Little research has involved associates (CRAs) formally, despite central role in process recruitment. The current study was initiated explore factors that influence with cancer regarding entry, specifically perspective CRA. METHODS Two focus groups CRAs Hamilton Regional Cancer Center were organized. A skilled facilitator guided both through exploratory subsequent confirmatory phases discussions, which audiotaped for review coding using consensus employing intercoder triangulation. RESULTS The two identified number they believed influenced recruitment process. Numerous physician patient reaffirmed, such as impression scientific merit or sense personal benefit, respectively. More uniquely, information transfer within informed consent major aspect specialized role. It full disclosure information, terms content techniques styles delivery, an important predictor success. quickly reached on most overall respect influencing recruitment. CONCLUSIONS CRAs appear unique recruiting active trials. They believe Further validate this is required, because, ultimately, greater understanding relative roles and, potentially, CRA will be development ethical supportive strategies optimize randomized 2002;95:1584–91. © 2002 American Society. DOI 10.1002/cncr.10864

参考文章(32)
Winn Rj, Obstacles to the accrual of patients to clinical trials in the community setting. Seminars in Oncology. ,vol. 21, pp. 112- 117 ,(1994)
Constance Engelking, Facilitating clinical trials: The expanding role of the nurse Cancer. ,vol. 67, pp. 1793- 1797 ,(1991) , 10.1002/CNCR.2820671818
N K Aaronson, E Visser-Pol, G H Leenhouts, M J Muller, A C van der Schot, F S van Dam, R B Keus, C C Koning, W W ten Bokkel Huinink, J A van Dongen, R Dubbelman, Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. Journal of Clinical Oncology. ,vol. 14, pp. 984- 996 ,(1996) , 10.1200/JCO.1996.14.3.984
Terrance L. Albrecht, Christina Blanchard, John C. Ruckdeschel, Michael Coovert, Rebecca Strongbow, Strategic Physician Communication and Oncology Clinical Trials Journal of Clinical Oncology. ,vol. 17, pp. 3324- 3332 ,(1999) , 10.1200/JCO.1999.17.10.3324
L A Siminoff, J H Fetting, M D Abeloff, Doctor-patient communication about breast cancer adjuvant therapy Journal of Clinical Oncology. ,vol. 7, pp. 1192- 1200 ,(1989) , 10.1200/JCO.1989.7.9.1192
WJ Mackillop, MJ Palmer, B O'Sullivan, GK Ward, R Steele, G Dotsikas, Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment. British Journal of Cancer. ,vol. 59, pp. 388- 395 ,(1989) , 10.1038/BJC.1989.78
G. Ross Langley, Heather J. Sutherland, Samuel Wong, Salomon Minkin, Hilary A. Llewellyn-Thomas, James E. Till, Why are (or are not) patients given the option to enter clinical trials? Controlled Clinical Trials. ,vol. 8, pp. 49- 59 ,(1987) , 10.1016/0197-2456(87)90025-0
L. Fallowfield, D. Ratcliffe, R. Souhami, Clinicians' attitudes to clinical trials of cancer therapy European Journal of Cancer. ,vol. 33, pp. 2221- 2229 ,(1997) , 10.1016/S0959-8049(97)00253-0
Peter M. Ellis, Sharon M. Dowsett, Phyllis N. Butow, Martin H.N. Tattersall, Attitudes to randomized clinical trials amongst out‐patients attending a medical oncology clinic Health Expectations. ,vol. 2, pp. 33- 43 ,(1999) , 10.1046/J.1369-6513.1999.00028.X